Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASR Grupo Aeroportuario del Sureste	$301.28 -1.8%	$319.37	$248.88 ▼ $360.00	$9.04B	0.76	51,442 shs	89,742 shs
CEE The Central and Eastern Europe Fund	$15.24 +0.9%	$15.00	$9.82 ▼ $17.11	N/A	1.22	40,607 shs	48,640 shs
CNL Cleco	$9.76 +120.1%	$0.00	$2.43 ▼ $12.00	$462.99M	N/A	35,840 shs	4,285 shs
TXG 10x Genomics	$10.81 -0.6%	$9.03	$6.78 ▼ $24.76	$1.33B	1.99	2.59 million shs	3.66 million shs

20 Stocks to Sell Now

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASR Grupo Aeroportuario del Sureste	0.00%	-3.79%	-12.94%	+5.76%	-4.41%
CEE The Central and Eastern Europe Fund	0.00%	-0.36%	-2.34%	+1.77%	+48.92%
CNL Cleco	0.00%	-3.27%	-12.74%	-5.19%	-82.38%
TXG 10x Genomics	0.00%	+3.84%	+32.31%	+4.04%	-44.96%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ASR Grupo Aeroportuario del Sureste	1.7426 of 5 stars	1.0	5.0	1.7	0.0	3.6	0.0	1.3
CEE The Central and Eastern Europe Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CNL Cleco	0.208 of 5 stars	1.7	0.0	0.0	0.0	0.0	0.0	0.6
TXG 10x Genomics	4.3688 of 5 stars	4.2	1.0	0.0	4.8	2.3	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ASR Grupo Aeroportuario del Sureste	2.00	Hold	$310.00	2.90% Upside
CEE The Central and Eastern Europe Fund	0.00	N/A	N/A	N/A
CNL Cleco	3.33	Buy	$8.00	-18.00% Downside
TXG 10x Genomics	2.38	Hold	$15.81	46.23% Upside

Current Analyst Ratings Breakdown

Latest CNL, CEE, TXG, and ASR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/11/2025	TXG 10x Genomics	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E+)
5/24/2025	TXG 10x Genomics	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E+)
5/19/2025	ASR Grupo Aeroportuario del Sureste	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Sector Outperform ➝ Sector Perform
5/19/2025	TXG 10x Genomics	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$26.00 ➝ $18.00
5/15/2025	TXG 10x Genomics	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$14.00 ➝ $14.00
5/13/2025	TXG 10x Genomics	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$14.00 ➝ $12.00
5/12/2025	TXG 10x Genomics	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sell ➝ Sell	$7.50 ➝ $6.50
5/12/2025	TXG 10x Genomics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$18.00 ➝ $15.00
5/10/2025	TXG 10x Genomics	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E+)
5/9/2025	TXG 10x Genomics	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$12.00 ➝ $9.00
4/24/2025	TXG 10x Genomics	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (E+)

(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ASR Grupo Aeroportuario del Sureste	$1.72B	5.26	$29.95 per share	10.06	$112.75 per share	2.67
CEE The Central and Eastern Europe Fund	N/A	N/A	N/A	N/A	N/A	N/A
CNL Cleco	N/A	N/A	N/A	N/A	N/A	N/A
TXG 10x Genomics	$610.78M	2.18	N/A	N/A	$5.81 per share	1.86

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ASR Grupo Aeroportuario del Sureste	$743.97M	$26.55	11.35	13.64	7.56	50.07%	25.70%	19.01%	7/22/2025 (Estimated)
CEE The Central and Eastern Europe Fund	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	6/27/2025 (Estimated)
CNL Cleco	-$19.13M	-$0.34	N/A	N/A	N/A	N/A	-129.04%	-104.12%	N/A
TXG 10x Genomics	-$182.63M	-$1.30	N/A	N/A	N/A	-25.14%	-23.22%	-18.02%	8/6/2025 (Estimated)

Latest CNL, CEE, TXG, and ASR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/8/2025	Q1 2025	TXG 10x Genomics	-$0.45	-$0.36	+$0.09	-$0.28	$131.91 million	$154.88 million
4/22/2025	Q1 2025	ASR Grupo Aeroportuario del Sureste	$5.77	$5.74	-$0.03	$5.74	$462.98 million	$430.05 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ASR Grupo Aeroportuario del Sureste	$23.14	7.68%	N/A	87.16%	N/A
CEE The Central and Eastern Europe Fund	$0.35	2.30%	N/A	N/A	N/A
CNL Cleco	N/A	N/A	N/A	N/A	N/A
TXG 10x Genomics	N/A	N/A	N/A	N/A	N/A

Latest CNL, CEE, TXG, and ASR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/28/2025	ASR Grupo Aeroportuario del Sureste	annual	$24.5850	8.6%	5/28/2025	5/28/2025	6/9/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ASR Grupo Aeroportuario del Sureste	0.18	5.16	5.16
CEE The Central and Eastern Europe Fund	N/A	N/A	N/A
CNL Cleco	0.01	4.36	4.36
TXG 10x Genomics	N/A	5.37	4.68

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ASR Grupo Aeroportuario del Sureste	10.57%
CEE The Central and Eastern Europe Fund	34.41%
CNL Cleco	N/A
TXG 10x Genomics	84.68%

Insider Ownership

Company	Insider Ownership
ASR Grupo Aeroportuario del Sureste	N/A
CEE The Central and Eastern Europe Fund	0.11%
CNL Cleco	1.55%
TXG 10x Genomics	10.03%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ASR Grupo Aeroportuario del Sureste	1,936	30.00 million	N/A	Optionable
CEE The Central and Eastern Europe Fund	N/A	N/A	N/A	Not Optionable
CNL Cleco	N/A	77.68 million	76.48 million	Not Optionable
TXG 10x Genomics	1,240	123.13 million	110.78 million	Optionable

CNL, CEE, TXG, and ASR Headlines

Recent News About These Companies

GAMMA Investing LLC Has $273,000 Holdings in 10x Genomics (NASDAQ:TXG)

June 22 at 3:02 AM | marketbeat.com

Delta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To Know

June 17, 2025 | msn.com

10x Genomics, Inc. (NASDAQ:TXG) Stock Position Decreased by Assenagon Asset Management S.A.

June 14, 2025 | marketbeat.com

Weiss Ratings Reaffirms "Sell (E+)" Rating for 10x Genomics (NASDAQ:TXG)

June 12, 2025 | marketbeat.com

Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns

June 10, 2025 | msn.com

TXG Q1 Earnings Call: Academic Funding Uncertainty Drives Guidance Withdrawal and Cost Reductions

June 10, 2025 | msn.com

10x Genomics (NASDAQ:TXG) Stock Price Up 8% - Time to Buy?

June 9, 2025 | marketbeat.com

10x Genomics (NASDAQ:TXG) Trading Down 4.6% - What's Next?

June 3, 2025 | marketbeat.com

Jefferies Financial Group Inc. Lowers Holdings in 10x Genomics, Inc. (NASDAQ:TXG)

June 1, 2025 | marketbeat.com

10x Genomics, Inc. (NASDAQ:TXG) Given Average Recommendation of "Hold" by Analysts

May 31, 2025 | marketbeat.com

10x Genomics (NASDAQ:TXG) Trading Up 4.2% - Still a Buy?

May 30, 2025 | marketbeat.com

Insider Selling: 10x Genomics, Inc. (NASDAQ:TXG) CFO Sells 4,044 Shares of Stock

May 29, 2025 | marketbeat.com

Insider Selling: 10x Genomics, Inc. (NASDAQ:TXG) Insider Sells 7,485 Shares of Stock

May 29, 2025 | marketbeat.com

Insider Selling: 10x Genomics, Inc. (NASDAQ:TXG) CEO Sells 9,343 Shares of Stock

May 29, 2025 | marketbeat.com

Wall Street Analysts Think 10x Genomics (TXG) Could Surge 43.12%: Read This Before Placing a Bet

May 29, 2025 | zacks.com

Adam Taich Sells 4,044 Shares of 10x Genomics, Inc. (NASDAQ:TXG) Stock

May 28, 2025 | insidertrades.com

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 193,588 Shares of 10x Genomics, Inc. (NASDAQ:TXG)

May 28, 2025 | marketbeat.com

10x Genomics' (TXG) "Sell (E+)" Rating Reiterated at Weiss Ratings

May 28, 2025 | marketbeat.com

Squarepoint Ops LLC Sells 121,729 Shares of 10x Genomics, Inc. (NASDAQ:TXG)

May 26, 2025 | marketbeat.com

10x Genomics, Inc. (NASDAQ:TXG) Shares Purchased by Man Group plc

May 26, 2025 | marketbeat.com

10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of America Corp DE

May 26, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Stocks That Will Profit From a Golden Dome
By Chris Markoch | May 30, 2025
View 3 Defense Stocks That Will Profit From a Golden Dome
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
Intel’s Turnaround May Be the Best Bet No One’s Watching
By Jeffrey Neal Johnson | May 30, 2025
View Intel’s Turnaround May Be the Best Bet No One’s Watching
3 Dividend Stocks Just Hiked Payouts 10%+ and Beat the Market
By Leo Miller | May 27, 2025
View 3 Dividend Stocks Just Hiked Payouts 10%+ and Beat the Market

CNL, CEE, TXG, and ASR Company Descriptions

Grupo Aeroportuario del Sureste NYSE:ASR

$301.27 -5.43 (-1.77%)

Closing price 06/20/2025 03:59 PM Eastern

Extended Trading

$301.19 -0.08 (-0.03%)

As of 06/20/2025 04:11 PM Eastern

Grupo Aeroportuario del Sureste, S. A. B. de C. V. holds concessions to operate, maintain, and develop airports in the southeast region of Mexico. The company operates airports that are located in the cities of Cancún, Cozumel, Mérida, Huatulco, Oaxaca, Veracruz, Villahermosa, Tapachula, and Minatitlán. It provides aeronautical services, which include passenger, aircraft landing and parking, passenger walkway, and airport security services. The company also offers non-aeronautical services, such as leasing of space at its airports to retailers, restaurants, airlines, and other commercial tenants; catering, handling, and ground transportation services, as well as engages in the various commercial operations. In addition, it holds concessions to operate the Luis Muñoz Marín International Airport in San Juan, Puerto Rico; and various airports in Colombia, including the Enrique Olaya Herrera Airport in Medellín, the José María Córdova International Airport in Rionegro, the Los Garzones Airport in Montería, the Antonio Roldán Betancourt Airport in Carepa, the El Caraño Airport in Quibdó, and the Las Brujas Airport in Corozal. Grupo Aeroportuario del Sureste, S. A. B. de C. V. was founded in 1996 and is headquartered in Mexico City, Mexico.

The Central and Eastern Europe Fund NYSE:CEE

$15.24 +0.14 (+0.89%)

Closing price 06/20/2025 03:58 PM Eastern

Extended Trading

$15.24 0.00 (0.00%)

As of 06/20/2025 04:04 PM Eastern

The Central and Eastern Europe Fund, Inc. is a closed ended equity mutual fund launched by Deutsche Investment Management Americas Inc. The fund is managed by Deutsche Asset Management International GmbH. It invests in the public equity markets across Central and Eastern Europe. The fund seeks to invest in stocks of companies operating across diversified sectors. It benchmarks the performance of its portfolio against the CECE, RTX, and ISE National 30. The fund was formerly known as The Central Europe And Russia Fund, Inc. The Central and Eastern Europe Fund, Inc. was formed on March 6, 1990 and is domiciled in the United States.

Cleco NYSE:CNL

Cleco Corporate Holdings LLC, formerly Cleco Corporation, is a public utility holding company. The Company's segments include Cleco Power and Other. Cleco Power is a regulated electric utility company that owns over 10 generating units with a total nameplate capacity of approximately 3,330 megawatts (MW) and serves approximately 287,000 customers in Louisiana through its retail business and supplies wholesale power in Louisiana and Mississippi. The Company, through its subsidiaries, owns one transmission substation in Louisiana and one transmission substation in Mississippi. Cleco Power is engaged in the generation, transmission, distribution and sale of electricity within Louisiana. It owns natural gas pipelines and interconnections at all of its generating facilities, which allow it to access various natural gas supply markets and maintain an economical fuel supply for its customers. The Company holds investments in its subsidiary, Cleco Power LLC (Cleco Power).

10x Genomics NASDAQ:TXG

$10.81 -0.06 (-0.55%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$10.74 -0.07 (-0.65%)

As of 06/20/2025 07:56 PM Eastern

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time